These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37043558)

  • 1. Efficacy of a brain-penetrant antiviral in lethal Venezuelan and eastern equine encephalitis mouse models.
    Cao X; Yang D; Parvathareddy J; Chu YK; Kim EJ; Fitz-Henley JN; Li X; Lukka PB; Parmar KR; Temrikar ZH; Dhole P; Adcock RS; Gabbard J; Bansal S; Lee J; Zalduondo L; Hayes E; Stabenow J; Meibohm B; Fitzpatrick EA; Bailey K; Campos RK; Julander JG; Rossi SL; Chung D; Jonsson CB; Golden JE
    Sci Transl Med; 2023 Apr; 15(691):eabl9344. PubMed ID: 37043558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of a ML336 derivative against Venezuelan and eastern equine encephalitis viruses.
    Jonsson CB; Cao X; Lee J; Gabbard JD; Chu YK; Fitzpatrick EA; Julander J; Chung DH; Stabenow J; Golden JE
    Antiviral Res; 2019 Jul; 167():25-34. PubMed ID: 30970271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Monovalent and Trivalent MVA-Based Vaccine Completely Protects Mice Against Lethal Venezuelan, Western, and Eastern Equine Encephalitis Virus Aerosol Challenge.
    Henning L; Endt K; Steigerwald R; Anderson M; Volkmann A
    Front Immunol; 2020; 11():598847. PubMed ID: 33542715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Insect-Specific Eilat Virus-Based Chimeric Vaccine Candidates Provide Durable, Mono- and Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.
    Erasmus JH; Seymour RL; Kaelber JT; Kim DY; Leal G; Sherman MB; Frolov I; Chiu W; Weaver SC; Nasar F
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29187545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of FDA-Approved Anti-Inflammatory Drugs Against Venezuelan Equine Encephalitis Virus Infection.
    Risner K; Ahmed A; Bakovic A; Kortchak S; Bhalla N; Narayanan A
    Viruses; 2019 Dec; 11(12):. PubMed ID: 31842327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of a novel compound with anti-venezuelan equine encephalitis virus activity that targets the nonstructural protein 2.
    Chung DH; Jonsson CB; Tower NA; Chu YK; Sahin E; Golden JE; Noah JW; Schroeder CE; Sotsky JB; Sosa MI; Cramer DE; McKellip SN; Rasmussen L; White EL; Schmaljohn CS; Julander JG; Smith JM; Filone CM; Connor JH; Sakurai Y; Davey RA
    PLoS Pathog; 2014 Jun; 10(6):e1004213. PubMed ID: 24967809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ablation of Programmed -1 Ribosomal Frameshifting in Venezuelan Equine Encephalitis Virus Results in Attenuated Neuropathogenicity.
    Kendra JA; de la Fuente C; Brahms A; Woodson C; Bell TM; Chen B; Khan YA; Jacobs JL; Kehn-Hall K; Dinman JD
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27852852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venezuelan and western equine encephalitis virus E1 liposome antigen nucleic acid complexes protect mice from lethal challenge with multiple alphaviruses.
    Rico AB; Phillips AT; Schountz T; Jarvis DL; Tjalkens RB; Powers AM; Olson KE
    Virology; 2016 Dec; 499():30-39. PubMed ID: 27632563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small molecule inhibitors of Ago2 decrease Venezuelan equine encephalitis virus replication.
    Madsen C; Hooper I; Lundberg L; Shafagati N; Johnson A; Senina S; de la Fuente C; Hoover LI; Fredricksen BL; Dinman J; Jacobs JL; Kehn-Hall K
    Antiviral Res; 2014 Dec; 112():26-37. PubMed ID: 25448087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in the Development of Small Molecule Antivirals against Equine Encephalitic Viruses.
    Ogorek TJ; Golden JE
    Viruses; 2023 Feb; 15(2):. PubMed ID: 36851628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant Isfahan Virus and Vesicular Stomatitis Virus Vaccine Vectors Provide Durable, Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.
    Nasar F; Matassov D; Seymour RL; Latham T; Gorchakov RV; Nowak RM; Leal G; Hamm S; Eldridge JH; Tesh RB; Clarke DK; Weaver SC
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28148802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of Venezuelan Equine Encephalitis Virus Identified Based on Host Interaction Partners of Viral Non-Structural Protein 3.
    Bakovic A; Bhalla N; Alem F; Campbell C; Zhou W; Narayanan A
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined alphavirus replicon particle vaccine induces durable and cross-protective immune responses against equine encephalitis viruses.
    Reed DS; Glass PJ; Bakken RR; Barth JF; Lind CM; da Silva L; Hart MK; Rayner J; Alterson K; Custer M; Dudek J; Owens G; Kamrud KI; Parker MD; Smith J
    J Virol; 2014 Oct; 88(20):12077-86. PubMed ID: 25122801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homoseongomycin, a compound isolated from marine actinomycete bacteria K3-1, is a potent inhibitor of encephalitic alphaviruses.
    Lin SC; Lehman CW; Stewart AK; Panny L; Bracci N; Wright JLC; Paige M; Strangman WK; Kehn-Hall K
    Antiviral Res; 2021 Jul; 191():105087. PubMed ID: 33965437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designing multivalent immunogens for alphavirus vaccine optimization.
    Read CM; Plante K; Rafael G; Rossi SL; Braun W; Weaver SC; Schein CH
    Virology; 2021 Sep; 561():117-124. PubMed ID: 33823988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venezuelan Equine Encephalitis Virus Induces Apoptosis through the Unfolded Protein Response Activation of EGR1.
    Baer A; Lundberg L; Swales D; Waybright N; Pinkham C; Dinman JD; Jacobs JL; Kehn-Hall K
    J Virol; 2016 Jan; 90(7):3558-72. PubMed ID: 26792742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody Preparations from Human Transchromosomic Cows Exhibit Prophylactic and Therapeutic Efficacy against Venezuelan Equine Encephalitis Virus.
    Gardner CL; Sun C; Luke T; Raviprakash K; Wu H; Jiao JA; Sullivan E; Reed DS; Ryman KD; Klimstra WB
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28468884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human cathelicidin peptide LL-37 as a therapeutic antiviral targeting Venezuelan equine encephalitis virus infections.
    Ahmed A; Siman-Tov G; Keck F; Kortchak S; Bakovic A; Risner K; Lu TK; Bhalla N; de la Fuente-Nunez C; Narayanan A
    Antiviral Res; 2019 Apr; 164():61-69. PubMed ID: 30738837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of the Ubiquitin-Mediated Signaling Pathway Exhibit Broad-Spectrum Antiviral Activities against New World Alphaviruses.
    Boghdeh NA; McGraw B; Barrera MD; Anderson C; Baha H; Risner KH; Ogungbe IV; Alem F; Narayanan A
    Viruses; 2023 Feb; 15(3):. PubMed ID: 36992362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineered Mesenchymal Cells Improve Passive Immune Protection Against Lethal Venezuelan Equine Encephalitis Virus Exposure.
    Braid LR; Hu WG; Davies JE; Nagata LP
    Stem Cells Transl Med; 2016 Aug; 5(8):1026-35. PubMed ID: 27334491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.